Events

Brian Rasquinha, Associate Director, Solution Architecture at Privacy Analytics, will be moderating a panel discussion on Pragmatic Statistical De-Identification. Guest panelists: Lauren Groebe, Associate General Counsel – Privacy, Cybersecurity & Digital, Baxter International, and John House, Executive Director, Science and Technology, Premier Applied Sciences.

Obaraboye Olude, Privacy Analytics’ Senior Clinical Trial Transparency Advisor and Manager will be presenting with Craig Tipple, Medical Director at DNDi on February 25 (1:30pm - 2:15pm ET). CASE STUDY: Balancing Data Sharing and Privacy in Neglected Tropical Disease Research.

Abby McDonell, Privacy Analytics’ Senior Program and Project Manager, Clinical Trial Transparency, will be presenting at the Conference on Thursday, November 7 (10:00am–10:30am CET)

Santa Borel, Associate Director, Data Privacy Solutions at Privacy Analytics will be moderating a panel discussion on Privacy Regulation and Real-World Applications for Generative AI in Healthcare. Guest panelists: Kelly Ko, Vice President, Innovation & Strategic Initiatives, Sharp HealthCare and Jiayan Chen, Partner, McDermott Will & Emery.

Privacy Analytics will be exhibiting (booth #419) at IAPP’s Privacy. Security. Risk. Conference September 23-24, 2024 in Los Angeles.

In this webinar, we’ll explore 10 non-technical best practices for HIPAA Expert Determination aimed at reducing timelines, rework, and costs while maximizing the organizational benefit from the data de-identification project.

Brian Rasquinha, Associate Director, Solution Architecture at Privacy Analytics will be moderating a panel discussion on Using De-Identification to Safely Enable Innovation and Commercialization. Guest panelists: Lauren Jones, Senior Privacy Counsel, Surescripts, and Jennifer Geetter, Partner, McDermott Will & Emery, LLP.

In this talk Axelle de Bruyne and Niamh McGuinness will share sponsor and vendor perspectives respectively on Argenx’s first PRCI submission, and some perspectives on collaborative best practices in setting up an effective and timely submission.

Join Niamh McGuinness, Associate Director, Safety, Regulatory & Transparency, to find out what makes a clinical document transparency-friendly, how do you incorporate best practices into your current initiatives, and how can our complete solution help you satisfy 3 key requirements – EMA Policy 0070, EU CTR, and Health Canada’s PRCI.

Niamh McGuinness, Senior Advisor, Clinical Trial Transparency and Privacy, will be presenting at the Conference on November 6 (3:00pm - 3:35pm CET). Presentation Topic: Utilising innovative technologies to streamline the publication of anonymized clinical trial documents and ensure protection of commercially confidential information